Cargando…

Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma

BACKGROUND: Differentially expressed gene profiles have previously been observed among pathologically defined cancers by microarray technologies, including head and neck squamous cell carcinomas (HNSCCs). However, the molecular expression signatures and transcriptional regulatory controls that under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Bin, Yang, Xinping, Lee, Tin-Lap, Friedman, Jay, Tang, Jun, Van Waes, Carter, Chen, Zhong
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929156/ https://www.ncbi.nlm.nih.gov/pubmed/17498291 http://dx.doi.org/10.1186/gb-2007-8-5-r78

Ejemplares similares

Unraveling Regulatory Programs for NF-kappaB, p53 and MicroRNAs in Head and Neck Squamous Cell Carcinoma
por: Yan, Bin, et al.
Publicado: (2013)

Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?
por: Morgan, Ethan L., et al.
Publicado: (2020)

Genomics and advances towards precision medicine for head and neck squamous cell carcinoma
por: Van Waes, Carter, et al.
Publicado: (2017)

Systems biology-defined NF-κB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status
por: Yan, Bin, et al.
Publicado: (2008)

TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers
por: Freudlsperger, Christian, et al.
Publicado: (2012)

Inhibition of transcription factor nuclear factor-κB by a mutant inhibitor-κBα attenuates resistance of human head and neck squamous cell carcinoma to TNF-α caspase-mediated cell death
por: Duffey, D C, et al.
Publicado: (2000)

The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2018)

Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer
por: Caponio, Vito Carlo Alberto, et al.
Publicado: (2020)

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma
por: Toni, Tiffany, et al.
Publicado: (2023)

Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC)
por: Morgan, Ethan L., et al.
Publicado: (2023)

Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas
por: An, Yi, et al.
Publicado: (2021)

MEK Inhibitor PD-0325901 Overcomes Resistance to CK2 Inhibitor CX-4945 and Exhibits Anti-Tumor Activity in Head and Neck Cancer
por: Bian, Yansong, et al.
Publicado: (2015)

Malignant and Nonmalignant Gene Signatures in Squamous Head and Neck Cancer
por: Worsham, Maria J., et al.
Publicado: (2012)

Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma
por: Li, Cheng, et al.
Publicado: (2020)

Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer
por: Nottingham, Liesl K., et al.
Publicado: (2013)

Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma
por: Liu, Jie, et al.
Publicado: (2022)

CK2 Phosphorylates and Inhibits TAp73 Tumor Suppressor Function to Promote Expression of Cancer Stem Cell Genes and Phenotype in Head and Neck Cancer()()
por: Lu, Hai, et al.
Publicado: (2014)

Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes
por: Sievers, Cem, et al.
Publicado: (2021)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
por: Mineta, H., et al.
Publicado: (1998)

TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB c-REL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer
por: Si, Han, et al.
Publicado: (2016)

Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches
por: Allen, Clint T., et al.
Publicado: (2015)

Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
por: Elghouche, Alhasan, et al.
Publicado: (2016)

p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
por: Ganly, I, et al.
Publicado: (2000)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
por: de Bakker, Tycho, et al.
Publicado: (2022)

p53 codon 72 polymorphism association with head and neck squamous cell carcinoma
por: Mojtahedi, Zahra, et al.
Publicado: (2015)

Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma
por: Qadir, Fatima, et al.
Publicado: (2019)

Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures
por: Mes, Steven W., et al.
Publicado: (2020)

Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma
por: Liu, Chang, et al.
Publicado: (2021)

Mast cell marker gene signature in head and neck squamous cell carcinoma
por: Cai, Zhimou, et al.
Publicado: (2022)

Proteome and phosphoproteome signatures of recurrence for HPV(+) head and neck squamous cell carcinoma
por: Kaneko, Tomonori, et al.
Publicado: (2022)

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
por: Lin, Cheng, et al.
Publicado: (2023)

The role of genetic factors in predisposition to squamous cell cancer of the head and neck
por: Jefferies, S, et al.
Publicado: (1999)

Incidence of Etiologic Factors in Squamous Cell Carcinoma of Head and Neck in Ahvaz
por: Nikakhlagh, Soheila, et al.
Publicado: (2012)

Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember
por: Solomon, Iulia, et al.
Publicado: (2018)

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma
por: Magnes, Teresa, et al.
Publicado: (2021)

Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma
por: Barsouk, Adam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vk00u75sqtl9kni2ji1or6kl39